Blog

In a groundbreaking study, researchers have revealed that teclistamab, a novel bispecific immunotherapy, has significantly improved survival rates and deepened remissions in patients suffering from...

On May 29, 2026, Memorial Sloan Kettering Cancer Center (MSK) proudly launched its third annual NYC for MSK campaign, a significant fundraising initiative that highlights the importance of community...

In a groundbreaking study published on May 29, 2026, researchers have unveiled a detailed map of tertiary lymphoid structures (TLSs), specialized immune cell formations found in and around tumors....

Recent research from Moffitt Cancer Center has shed light on uveal melanoma, the most common eye cancer in adults, particularly focusing on its propensity to spread to the liver. This revelation is...

Recent research from the Moffitt Cancer Center has shed light on a crucial aspect of uveal melanoma, the most common form of eye cancer. The study reveals how this aggressive cancer often...

Recent research from the Mayo Clinic has unveiled an important shift in how we approach the treatment of early-stage pancreatic cancer. The study suggests that administering chemotherapy before...

The recent case at Children’s Hospital Los Angeles involving a child diagnosed with high-risk medulloblastoma demonstrates a significant shift in how oncologists are approaching cancer treatment....

The recent announcement that three researchers from UTHealth Houston have received over $6 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) highlights a...

In a significant step towards enhancing patient care and advancing cancer research, Advocate Health announced a partnership with the AI startup Lind to streamline the process of connecting cancer...

In a significant advancement for cancer research, scientists from the Wistar Institute and Temple University have uncovered a metabolic target that may help overcome chemotherapy resistance in...

The latest breakthroughs in cancer research were showcased at the American Society of Clinical Oncology (ASCO) Annual Meeting in 2026, where the Mayo Clinic Comprehensive Cancer Center presented over...

The recent announcement from the American Society of Clinical Oncology (ASCO) honoring Dr. Sharon Giordano and Dr. Eduardo Vilar-Sanchez from The University of Texas MD Anderson Cancer Center...

The recent recognition of Dr. Sharon Giordano and Dr. Eduardo Vilar-Sanchez at the American Society of Clinical Oncology (ASCO) Annual Meeting underscores a pivotal moment in the field of cancer...

In a significant development for cancer research, Panome Bio and TD2 Oncology have announced a strategic partnership aimed at advancing translational oncology through integrated multi-omics...

In a significant development for the cancer research community, three researchers from UTHealth Houston have been awarded over $6 million in funding by the Cancer Prevention and Research Institute of...

In an exciting development for cancer research, researchers at UC San Diego have unveiled a groundbreaking artificial intelligence model that can predict a patient's response to cancer treatments...

As the landscape of cancer treatment continues to evolve, recent advancements from Cedars-Sinai Cancer and The Angeles Clinic and Research Institute are set to capture the attention of the oncology...

Recent advancements in cancer research are paving the way for more effective treatments, particularly for patients battling blood cancers like leukemia and lymphoma. The John Theurer Cancer Center at...

As the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting approaches, excitement is building around the groundbreaking research being presented by the physician-scientists from...

Recent advancements in artificial intelligence (AI) are transforming the landscape of cancer treatment, offering hope to patients and healthcare providers alike. A groundbreaking study from...